Monitoring Therapeutic Response in a Case of Extrapulmonary Tuberculosis by Serial F-18 FDG PET/CT

Nuclear Medicine and Molecular Imaging

Volumn 46, Issue 1, 2012, Pages 69-72

  Park, Yong Hyun ^a   Yu, Chang Min ^a   Kim, Eun Sil ^a   Jung, Jun Oh ^a   Seo, Han Seok ^a   Lee, Ju Hyoung ^a   Hur, So Chong ^a   Kim, So Yeon ^a   Lee, Hyon Young ^a  

^a National Police Hospital   (South Korea)

Author keywords

Extrapulmonary tuberculosis; F 18 FDG PET CT; Tuberculosis

Indexed keywords

AMIKACIN; CYCLOSERINE; ETHAMBUTOL; FLUORODEOXYGLUCOSE F 18; ISONIAZID; LACTATE DEHYDROGENASE; LEVOFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN;

ABDOMINAL RADIOGRAPHY; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC IMAGING; DRUG RESPONSE; DRUG WITHDRAWAL; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEARING IMPAIRMENT; HUMAN; IMAGE DISPLAY; PATIENT MONITORING; PHYSICAL EXAMINATION; PLEURA EFFUSION; PLEURA FLUID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT PLANNING; TUBERCULIN TEST; TUBERCULOUS PLEURISY; VITAL SIGN;

EID: 84863001612     PISSN: 18693474     EISSN: 18693482     Source Type: Journal    
DOI: 10.1007/s13139-011-0114-8     Document Type: Article

References (16)

1. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003; 167: 603-62.
2. Ong A, Creasman J, Hopewell PC, Gonzalez LC, Wong M, Jasmer RM, et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis. 2004; 38: 25-31.
3. Phillips PP, Davies GR, Mitchison DA. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis. 2010; 10: 69-70.
4. Makis W, Abikhzer G, Stern J. Tuberculous synovitis of the hip joint diagnosed by FDG PET-CT. Clin Nucl Med. 2009; 34: 431-2.
5. Park IN, Ryu JS, Shim TS. Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med. 2008; 33: 1-3.
6. Demura Y, Tsuchida T, Uesaka D, Umeda Y, Morikawa M, Ameshima S, et al. Usefulness of 18 F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis. Eur J Nucl Med Mol Imaging. 2009; 36: 632-9.
7. Sanabe N, Ikematsu Y, Nishiwaki Y, Kida H, Murohisa G, Ozawa T, et al. Pancreatic tuberculosis. J Hepatobiliary Pancreat Surg. 2002; 9: 515-8.
8. Metser U, Even-Sapir E. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med. 2007; 37: 206-22.
9. Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology. 2000; 216: 117-21.
10. Yago Y, Yukihiro M, Kuroki H, Katsuragawa Y, Kubota K. Cold tuberculous abscess identified by FDG PET. Ann Nucl Med. 2005; 19: 515-8.
11. Meller J, Sahlmann CO, Scheel AK. 18 F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007; 48: 35-45.
12. Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, et al. Lymph node staging of gastric cancer using (18)F-FDG PET: A comparison study with CT. J Nucl Med. 2005; 46: 1582-8.
13. Hofmeyr A, Lau WF, Slavin MA. Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response. Tuberculosis. 2007; 87: 459-63.
14. Lee HS, Oh JY, Lee JH, Yoo CG, Lee CT, Kim YW, et al. Response of pulmonary tuberculomas to anti-tuberculous treatment. Eur Respir J. 2004; 23: 452-5.
15. Yang CM, Hsu CH, Lee CM, Wang FC. Intense uptake of [F-18]-fluoro-2 deoxy-D-glucose in active pulmonary tuberculosis. Ann Nucl Med. 2003; 17: 407-10.
16. Yoshioka T, Yamaguchi K, Kubota K, Saqinoya T, Yamazaki T, Ido T, et al. Evaluation of 18 F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med. 2003; 44: 690-9.